TranS1 Inc. TSON,
a medical device company focused on designing, developing and marketing
products to treat degenerative conditions of the spine affecting the lower
lumbar region, today announced that it had reached a tentative agreement in
principle with the U.S. Department of Justice related to the subpoena issued
in October 2011. On December 24, 2012, the Company and the staff of the
Department of Justice tentatively agreed to settle its federal investigation
for $6 million, subject to completion and approval of written settlement
agreements with the Department of Justice and the HHS-OIG, which are expected
to be finalized in the first few months of 2013. The Company admits no
wrongdoing as part of the settlement.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in